Capital Advisors Ltd’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-322
Closed -$1K 1637
2022
Q4
$1K Buy
+322
New +$849 ﹤0.01% 1157
2022
Q3
Sell
-98
Closed 1617
2022
Q2
$0 Buy
+98
New +$513 ﹤0.01% 1419

Other funds holding CELL

Capital Advisors Ltd's CELL Position: Q1 2023 in Review

Capital Advisors Ltd sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 322 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in CELL in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q4 2022. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Capital Advisors Ltd reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Capital Advisors Ltd sold 322 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $1K.
  • Capital Advisors Ltd first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Capital Advisors Ltd's PhenomeX Inc. Common Stock position peaked at $1K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Capital Advisors Ltd's 13F filing for Q1 2023, filed 3 May 2023.